(Q48390326)

11 February 2018

title

Altered neurochemical profile in the McGill-R-Thy1-APP rat model of Alzheimer's disease: a longitudinal in vivo 1 H MRS study. (English)

1 reference

11 February 2018

1 reference

5

Ursula Sonnewald

1 reference

11 February 2018

author name string

Linn H Nilsen

1

1 reference

11 February 2018

Torun M Melø

2

1 reference

11 February 2018

Oddbjørn Saether

3

1 reference

11 February 2018

Menno P Witter

4

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 October 2012

1 reference

11 February 2018

Journal of Neurochemistry

published in

1 reference

11 February 2018

volume

123

1 reference

11 February 2018

issue

4

1 reference

11 February 2018

page(s)

532-541

1 reference

11 February 2018

Regional N-acetylaspartate reduction in the hippocampus detected with fast proton magnetic resonance spectroscopic imaging in patients with Alzheimer disease

cites work

1 reference

Role of myo-inositol by magnetic resonance spectroscopy in early diagnosis of Alzheimer's disease in APP/PS1 transgenic mice

21 January 2018

1 reference

Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile

21 January 2018

1 reference

Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000).

21 January 2018

1 reference

Brain glutamate levels are decreased in Alzheimer's disease: a magnetic resonance spectroscopy study.

21 January 2018

1 reference

Regional and developmental variations in metabolite concentration in the rat brain and eye: a study using 1H NMR spectroscopy and high performance liquid chromatography.

21 January 2018

1 reference

Hippocampal proton MR spectroscopy in early Alzheimer's disease and mild cognitive impairment.

21 January 2018

1 reference

Decrease and recovery of N-acetylaspartate/creatine in rat brain remote from focal injury

21 January 2018

1 reference

Brain metabolism differs in Alzheimer's disease and Parkinson's disease dementia

21 January 2018

1 reference

Automatic, localized in vivo adjustment of all first- and second-order shim coils

21 January 2018

1 reference

Synaptic changes in Alzheimer's disease: increased amyloid-beta and gliosis in surviving terminals is accompanied by decreased PSD-95 fluorescence

21 January 2018

1 reference

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

21 January 2018

1 reference

Expression of glutamine synthetase and glutamate dehydrogenase in the latent phase and chronic phase in the kainate model of temporal lobe epilepsy

21 January 2018

1 reference

Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study

21 January 2018

1 reference

1 H MR Spectroscopy of the Brain: Absolute Quantification of Metabolites 1

21 January 2018

1 reference

Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD.

21 January 2018

1 reference

A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI.

21 January 2018

1 reference

Altered metabolic profile in the frontal cortex of PS2APP transgenic mice, monitored throughout their life span.

21 January 2018

1 reference

In vivo and ex vivo evidence for ketamine-induced hyperglutamatergic activity in the cerebral cortex of the rat: Potential relevance to schizophrenia.

21 January 2018

1 reference

Acute restraint-mediated increases in glutamate levels in the rat brain: an in vivo ¹H-MRS study at 4.7 T.

21 January 2018

1 reference

Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids

21 January 2018

1 reference

A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment

21 January 2018

1 reference

Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease

21 January 2018

1 reference

Astrocytes and the plaques of Alzheimer's disease

21 January 2018

1 reference

Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy

21 January 2018

1 reference

Metabolism is normal in astrocytes in chronically epileptic rats: a (13)C NMR study of neuronal-glial interactions in a model of temporal lobe epilepsy

21 January 2018

1 reference

N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology

21 January 2018

1 reference

Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

21 January 2018

1 reference

Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis.

21 January 2018

1 reference

Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b.

21 January 2018

1 reference

Distribution of glutamine synthetase in the rat central nervous system

21 January 2018

1 reference

Fine structural localization of glutamine synthetase in astrocytes of rat brain

21 January 2018

1 reference

21 January 2018

1 reference

Metabolic compartmentation of glutamate and glutamine: morphological evidence obtained by quantitative immunocytochemistry in rat cerebellum

21 January 2018

1 reference

21 January 2018

1 reference

Activation of GABA(A) receptors by taurine and muscimol blocks the neurotoxicity of beta-amyloid in rat hippocampal and cortical neurons

21 January 2018

1 reference

Brain glutamine synthetase increases following cerebral ischemia in the rat

21 January 2018

1 reference

In vivo brain concentrations of N-acetyl compounds, creatine, and choline in Alzheimer disease.

21 January 2018

1 reference

Analysis of glial acidic fibrillary protein in the human entorhinal cortex during aging and in Alzheimer's disease

21 January 2018

1 reference

Glutamine synthetase (GS) expression is reduced in senile dementia of the Alzheimer type.

21 January 2018

1 reference

Reduced hippocampal glutamate in Alzheimer disease

21 January 2018

1 reference

The profile of hippocampal metabolites differs between Alzheimer's disease and subcortical ischemic vascular dementia, as measured by proton magnetic resonance spectroscopy

21 January 2018

1 reference

Cerebral edema in developing brain: I. Normal water and cation content in developing rat brain and postmortem changes

21 January 2018

1 reference

Developmental and regional changes in the neurochemical profile of the rat brain determined by in vivo 1H NMR spectroscopy

21 January 2018

1 reference

Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease

21 January 2018

1 reference

Molecular identification of aspartate N-acetyltransferase and its mutation in hypoacetylaspartia

21 January 2018

1 reference

Mode of action of taurine as a neuroprotector

21 January 2018

1 reference

Volumetric MRI and MRS provide sensitive measures of Alzheimer's disease neuropathology in inducible Tau transgenic mice (rTg4510).

21 January 2018

1 reference

Metabonomic alterations in hippocampus, temporal and prefrontal cortex with age in rats.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JNC.12003

1 reference

11 February 2018

1 reference

11 February 2018